The FTC announced March 3 that commission staff recommended challenging the transaction after determining it would eliminate competition and raise healthcare costs in central Georgia. The FTC said the health systems’ decision to call off the deal is “great news” for patients.
“The proposed transaction threatened to increase healthcare costs for employers and patients in the region and would have substantially lessened competition that has benefited the community through expansion of healthcare services and improved quality of care,” acting FTC Chair Rebecca Kelly Slaughter said in a news release.
The commission voted 4-0 to disclose the investigation and close it.
More articles on healthcare industry transactions:
Troubled Pennsylvania health system looks for a buyer
FTC drops challenge to Philadelphia health system merger
UnityPoint Health sells Iowa hospital
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
